11β-Hydroxysteroid dehydrogenase in the brain: A novel regulator of glucocorticoid action?

Frontiers in Neuroendocrinology

Volumn 18, Issue 1, 1997, Pages 49-99

  Seckl, Jonathan R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

11 dehydrocorticosterone; corticosterone; glucocorticoid receptor; hypothalamic pituitary adrenal axis; mineralocorticoid receptor; neuronal death; prenatal programming

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE; CORTICOSTERONE; ENZYME INHIBITOR; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; GLUCOCORTICOID; HYDROXYSTEROID DEHYDROGENASE;

ANIMAL CELL; AVOIDANCE BEHAVIOR; BLOOD PRESSURE REGULATION; BRAIN DEVELOPMENT; CENTRAL NERVOUS SYSTEM; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEEDING BEHAVIOR; FETUS; HIPPOCAMPUS; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HUMAN CELL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIMBIC SYSTEM; MOOD; MOUSE; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROENDOCRINOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SALT INTAKE; STEROID METABOLISM; TISSUE DISTRIBUTION; ANIMAL; BRAIN; CHEMISTRY; ENZYMOLOGY; ISOMERISM; PHYSIOLOGY;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; BRAIN; GLUCOCORTICOIDS; HUMANS; HYDROXYSTEROID DEHYDROGENASES; ISOMERISM;

EID: 0030614522     PISSN: 00913022     EISSN: None     Source Type: Journal    
DOI: 10.1006/frne.1996.0143     Document Type: Article

References (265)

1. 1. Abramovitz M, Branchaud CL, Murphy BEP. Cortisol-cortisone interconversion in human fetal lung: Contrasting results using explants and monolayer cultures suggests that 11β-OHSD comprises two enzymes. J Clin Endocrinol Metab 1982; 54: 563-568.
2. 2. Agarwal AK, Monder C, Eckstein B, White PC. Cloning and expression of rat cDNA encoding corticosteroid 11-dehydrogenase. J Biol Chem 1989; 264: 18939-18943.
3. +-dependent isoform of 11β-hydroxysteroid dehydrogenase: Cloning and characterisation of cDNA from sheep kidney. J Biol Chem 1994; 269: 25959-25962.
4. 4. Agarwal AK, Mune T, Monder C, White PC. Mutations in putative glycosylation sites of rat 11β-hydroxysteroid dehydrogenase affect enzymatic activity. Biochem Biophys Acta 1995; 1248: 70-74.
5. 5. Agarwal AK, Rogerson FM, Mune T, White PC. Gene structure and chromosomal localization of the human HSD11K gene encoding the kidney (type 2) isozyme of 11β-hydroxysteroid dehydrogenase. Genomics 1995; 29: 195-199.
6. 6. Agarwal AK, Tusie-Luna M-T, Monder C, White PC. Expression of 11β-hydroxysteroid dehydrogenase using recombinant vaccinia virus. Mol Endocrinol 1990; 4: 1827-1832.
7. 7. Ahima RS, Harlan RE. Charting of type II glucocorticoid receptor-like immunoreactivity in the rat central nervous system. Neuroscience 1990; 39: 579-604.
8. 8. Ahima RS, Krozowski ZS, Harlan RE. Type I corticosteroid receptor-like immunoreactivity in the rat CNS: Distribution and regulation by corticosteroids. J Comp Neurol 1991; 313: 522-538.
9. 9. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS. Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol 1994; 105: R11-R17.
10. 10. Amelung D, Huebener HJ, Roka L, Meyerheim G. Conversion of cortisone to compound F. J Clin Endocrinol Metab 1953; 13:1125.
11. 11. Andersson S, Berman DM, Jenkins EP, Russell DW. Deletion of steroid 5a-reductase 2 gene in male pseudohermaphroditism. Nature 1991; 354: 159-161.
12. 12. Armanini D, Karbowiak I, Funder JW. Affinity of liquorice derivatives for mineralocorticoid and glucocorticoid receptors. Clin Endocrinol 1983; 19: 609-612.
13. 13. Arnolda L, Minson J, Kapoor V, Pilowsky P, Llewellyn Smith I, Chalmers J. Amino acid neurotransmitters in hypertension. Kidney Int Suppl 1992; S2-S7.
14. 14. Arriza JL, Simerly RB, Swanson LW, Evans RM. The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response. Neuron 1988; 1: 887-900.
15. 15. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM. Cloning of human mineralocorticoid receptor complementary DNA: Structural and functional kinship with the glucocorticoid receptor. Science 1987; 237: 268-275.
16. 16. Baggia S, Albrecht E, Pepe G. Regulation of 11β-hydroxysteroid dehydrogenase activity in the baboon placenta by estrogen. Endocrinology 1990; 126: 2742-2748.
17. 17. Baker ME. Licorice and enzymes other than 11beta-hydroxysteroid dehydrogenase: An evolutionary perspective. Steroids 1994; 59: 136-141.
18. 18. Baker ME, Fanestil DD. Liquorice, computer-based analyses of dehydrogenase sequences, and the regulation of steroid and protaglandin action. Mol Cell Endocrinol 1991; 78: C99-C102.
19. 19. Balaban CD, Schuerger RJ, Severs WB. Evidence for a noradrenergic projection to the subcommissural organ. Neurosci Lett 1994; 180: 209-213.
20. 20. Barker DJP, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and cardiovascular disease in adult life. Lancet 1993; 341: 938-941.
21. 21. Barker DJP, Hales CN, Fall CHD, Osmond C, Phipps K, Clarke PMS. Type 2 (non-insulin dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): Relation to reduced fetal growth. Diabetologia 1993; 36: 62-67.
22. 22. Beatty PA, Beatty WW, Bowman RE, Gilchrist JC. The effects of ACTH, adrenalectomy and dexamethasone on the acquisition of an avoidance response in rats. Physiol Behav 1970; 5: 939-944.
23. 23. Beitens IZ, Bayard F, Ances IG, Kowarski A, Migeon CJ. The metabolic clearance rate, blood production, interconversion and transplacental passage of cortisol and cortisone in pregnancy near term. Pediatr Res 1973; 7: 509-519.
24. 24. Benediktsson R, Brennand J, Tibi L, Calder AA, Seckl JR, Edwards CRW. Fetal osteocalcin levels are related to placental 11β-hydroxysteroid dehydrogenase activity. Clin Endocrinol 1995; 42: 551-555.
25. 25. Benediktsson R, Lindsay R, Noble J, Seckl JR, Edwards CRW. Glucocorticoid exposure in utero: A new model for adult hypertension. Lancet 1993; 341: 339-341.
26. 26. Benediktsson R, Noble J, Calder AA, Edwards CRW, Seckl JR. 11β-Hydroxysteroid dehydrogenase activity in intact dually-perfused fresh human placenta predicts birth weight. J Endocrinol 1995; 144(Suppl): P161.
27. 27. Berecek KH, Barron KW, Webb RL, Brody MJ. Vasopressin-central nervous system interactions in the development of DOCA hypertension. Hypertension 1982; 4: 131-137.
28. 28. Bian XP, Seidler FJ, Slotkin TA. Promotional role for glucocorticoids in the development of intracellular signalling: Enhanced cardiac and renal adenylate cyclase reactivity to β-adrenergic and non-adrenergic stimuli after low-dose fetal dexamethasone exposure. J Dev Physiol 1992; 17: 289-297.
29. 29. Birmingham MK, Sar M, Strumpf WE. Localization of aldosterone and corticosterone in the central nervous system assessed by quantitative autoradiography. Neurochem Res 1984; 9: 333-350.
30. 30. Bohn MC. Granule cell genesis in the hippocampus of rats treated neonatally with hydrocortisone. Neuroscience 1980; 5: 2003-2012.
31. 31. Bohus B, de Kloet ER, Veldhuis HD. Adrenal steroids and behavioural adaptation: relationship to brain corticosteroid receptors. In: Ganten D, Pfaff D, Eds. Current Topics in Neuroendocrinology. Berlin: Springer-Verlag, 1982: 107-148.
32. 32. Brinton RE, McEwen BS. Regional distinctions in the regulation of type I and type II adrenal steroid receptors in the central nervous system. Neurosci Res Commun 1988; 2: 37-45.
33. 33. Brody MJ, Johnson AK. Role of the anteroventral third ventricle region in fluid and electrolyte balance, arterial pressure regulation and hypertension. Front Neuroendocrinol 1980; 6: 249-267.
34. 34. Brown RW, Chapman KE, Edwards CRW, Seckl JR. Human placental 11β-hydroxysteroid dehydrogenase: Partial purification of and evidence for a distinct NAD-dependent isoform. Endocrinology 1993; 132: 2614-2621.
35. 35. Brown RW, Chapman KE, Edwards CRW, Seckl JR. Purification of 11β-hydroxysteroid dehydrogenase type 2 from human placenta. Biochem J 1996; 313: 997-1005.
36. 36. Brown RW, Chapman KE, Kotolevtsev Y, Yau JLW, Leckie C, Murad P, Lyons V, Edwards CRW, Seckl JR. Isolation and cloning of human placental 11β-hydroxysteroid dehydrogenase-2 cDNA. Biochem J 1996; 313: 1007-10017.
37. 37. Brown RW, Diaz R, Robson AC, Kotolevtsev Y, Mullins JJ, Kaufman MH, Seckl JR. The ontogeny of 11β-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development. Endocrinology 1996; 137: 794-797.
38. 38. Brown RW, Kotolevtsev Y, Leckie C, Lindsay RS, Lyons V, Murad P, Mullins JJ, Chapman KE, Edwards CRW, Seckl JR. Isolation and cloning of human placental 11β-hydroxysteroid dehydrogenase-2 cDNA. Biochem J 1996; 313: 1007-1017.
39. 39. Bühler H, Perschel FH, Hierholzer K. Inhibition of rat renal 11β-hydroxysteroid dehydrogenase by steroidal compounds and triterpenoids: Structure/function relationship. Biochim Biophys Acta 1991; 1075: 206-212.
40. 40. Burton AF, Tufnell RW. 11-Dehydrocorticosteroids in tissues of mice. Can J Biochem 1967; 46: 497-502.
41. 41. Bush IE. 11β-Hydroxysteroid dehydrogenase: Contrast between studies in vivo and studies in vitro. Adv Biosci 1969; 3: 23-39.
42. 42. Bush IE, Hunter SA, Meigs RA. Metabolism of 11-oxygenated steroids. Metabolism in vitro by preparation of liver. Biochem J 1968; 107: 239-258.
43. 43. Castaneyra-Perdomo A, Meyer G, Carmona Calero E, Banuelos Pinda J, Mendez Medina R, Ormazabal Ramos C, Ferres Torres R. Alterations of the subcommissural organ in the hydrocephalic human fetal brain. Dev Brain Res 1994; 79: 316-320.
44. 44. Cifuentes M, Rodriguez S, Ferez J, Grondona JM, Rodriguez EM, FernandezLlebrez P. Decreased cerebrospinal fluid flow through the central canal of the spinal cord of rats immunologically deprived of Reissner's fibre. Exp Brain Res 1994; 98: 431-440.
45. 45. Cole TJ. Cloning of the mouse 11 beta-hydroxysteroid dehydrogenase type 2 gene: Tissue specific expression and localization in distal convoluted tubules and collecting ducts of the kidney. Endocrinology 1995; 136: 4693-4696.
46. 46. de Kloet E, Kovács G, Szabó G, Telegdy G, Bohus B, Versteeg D. Decreased serotonin turnover in the dorsal hippocampus of the rat brain shortly after adrenalectomy: Selective normalization after corticosterone substitution. Brain Res 1982; 239: 659-663.
47. 47. de Kloet ER. Brain corticosteroid receptor balance and homeostatic control. Front Neuroendocrinol 1991; 12: 95-164.
48. 48. de Kloet ER, Rosenfeld P, van Eekelen JAM, Sutanto W, Levine S. Stress, glucocorticoids and development. Prog Brain Res 1988; 73: 101-116.
49. 49. de Kloet ER, Versteeg DHG, Kovacs GL. Aldosterone blocks the response to corticosterone in the raphe-hippocampal serotonin system. Brain Res 1983; 264: 323-327.
50. 50. De Vellis J, McEwen BS, Cole R, Inglish D. Relations between glucocorticoid nuclear binding, cytosol receptor activity and enzyme induction in a rat glial cell line. J Steroid Biochem 1974; 5: 392-393.
51. 51. Diaz R, Brown RW, Seckl JR. Corticosteroid receptors and 11β-hydroxysteroid dehydrogenases: Crucial regulators of glucocorticoid action during fetal brain development. In: Grauer E, Ben-Nathan D, Levy A, Eds. Proceedings 40th Oholo Conference. 1996.
52. 52. Diaz R, Ögren SO, Blum M, Fuxe K. Prenatal corticosterone increases spontaneous and d-amphetamine induced locomotor activity and brain dopamine metabolism in prepubertal male and female rats. Neuroscience 1995; 66:467-473.
53. 53. Dundore RL, Wurpel JND, Balaban CD, Keil LC, Severs WB. Central effects of aldosterone infused into the subcommissural organ region. Neurosci Res 1984; 1: 341-351.
54. 54. Duperrex H, Kenouch S, Gaeggeler H-P, Seckl JR, Edwards CRW, Farman N, Rossier BC. Rat liver 11β-hydroxysteroid dehydrogenase cDNA encodes oxoreductase activity in a mineralocorticoid-responsive toad bladder cell line. Endocrinology 1993; 132: 612-619.
55. 55. Edwards CRW, Benediktsson R, Lindsay R, Seckl JR. Dysfunction of the placental glucocor-ticoid barrier: A link between the foetal environment and adult hypertension? Lancet 1993; 341: 355-357.
56. 56. Edwards CRW, Hayman A. Enzyme protection of the mineralocorticoid receptor: Evidence in favour of the hemiacetal structure of aldosterone. In: Bonvalet J-P, Farman N, Lombes M, Rafestin-Oblin ME, Eds. Aldosterone: Fundamental aspects. Paris: INSERM/John Libbey Eurotext Ltd., 1991: 67-76.
57. 57. Edwards CRW, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS, de Kloet ER, Monder C. Localisation of 11β-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet 1988; ii: 986-989.
58. 58. Elliott EM, Sapolsky RM. Corticosterone impairs hippocampal neuronal calcium regulation-possible mediating mechanisms. Brain Res 1993; 602: 84-90.
59. 59. Evans RM. The steroid and thyroid hormone receptor superfamily. Science 1988; 240: 889-895.
60. 60. Ffrench-Mullen JMH, Danks P, Spence KT. Neurosteroids modulate calcium currents in hippocampal CA1 neurons via a pertussis toxin-sensitive G-protein-coupled mechanism. J Neurosci 1994; 14: 1963-1977.
61. 61. Fink GD, Buggy J, Johnson AK, Brody MJ. Prevention of steroid-salt hypertension in the rat by anterior forebrain lesions. Circulation 1977; 56(Suppl III): III-242.
62. 62. Fuller PJ, Verity K. Colonic sodium-potassium adenosine triphosphate subunit gene expression: Ontogeny and regulation by adrenocortical steroids. Endocrinology 1990; 127: 32-38.
63. 63. Funder JW A la recherche du temps perdu. In: Bonvalet J-P, Farman N, Lombes M, Rafestin-Oblin ME, Eds. Aldosterone: Fundamental Aspects. INSERM/John Libbey Eurotext Ltd., 1991: 77-83.
64. 64. Funder JW, Pearce PT, Smith R, Smith AI. Mineralocorticoid action: Target tissue specificity is enzyme, not receptor, mediated. Science 1988; 242: 583-585.
65. 65. Gaeggeler H-P, Edwards C, Rossier B. Steroid metabolism determines mineralocorticoid specificity in the toad bladder. Am J Physiol 1989; 257: F690-F695.
66. 66. Galaverna O, de Luca LAJr, Schulkin J, Yao S-Z, Epstein AN. Deficits in NaC1 ingestion after damage to the central nucleus of the amygdala in the rat. Brain Res Bull 1991; 28: 89-98.
67. 67. Ganjam VK, Gomez-Sanchez CE, Gomez-Sanchez EP, Chen YJ, Cox DL. High affinity NADP+-dependent 11β-hydroxysteroid dehydrogenase in sheep kidney and JEG-3 cells. Endocrine Soc Abstr 1995; 77: 413.
68. 68. Ghosh D, Weeks CM, Grochulski P, Duax WL, Erman M, Rimsay RL, Orr JC. Three dimensional structure of holo 3a,20β-hydroxysteroid dehydrogenase: a mamber of a short-chain ndehydrogenase family. Proc Natl Acad Sci USA 1991; 88: 10064-10068.
69. 69. Glass CK. Differential recognition of target genes by nuclear receptor monomers, dimers and heterodimers. Endocrine Rev 1994; 15: 391-407.
70. 70. Glock GE, McLean P. Levels of oxidized and reduced diphosphopyridine nucleotide and triphosphopyridine nucleotide in animal tissues. Biochem J 1955; 61: 388-390.
71. 71. Gomez-Sanchez EP. Intracerebroventricular infusion of aldosterone induces hypertension in rats. Endocrinology 1986; 118: 819-823.
72. 72. Gomez-Sanchez EP. What is the role of the central nervous system in mineralocorticoid hypertension? Am J Hypertens 1991; 4: 374-381.
73. 73. Gomez-Sanchez EP, Fort CM, Thwaites D. Icv infusion of corticosterone antagonises icvaldosterone hypertension. Am J Physiol 1990; E649-E653.
74. 74. Gomez-Sanchez EP, Gomez-Sanchez CE. Central hypertensinogenic effects of glycyrrhizic acid and carbenoxolone. Am J Physiol 1992; 263: E1125-E1130.
75. 75. Gomez-Sanchez EP, Fort C, Thwaites D. Central mineralocorticoid receptor antagonism blocks hypertension in Dahl S/JR rats. Am J Physiol 1992; 262: E96-E99.
76. 76. Gould E, Woolley CS, Cameron HA, Daniels DC, McEwen BS. Adrenal steroids regulate postnatal development in the rat dentate gyrus. II. Effects of glucocorticoids on cell birth. J Comp Neurol 1991; 313: 486-493.
77. 77. Gould E, Woolley CS, McEwen BS. Short-term glucocorticoid manipulations affect neuronal morphology and survival in the adult dentate gyrus. Neuroscience 1990; 37: 367-375.
78. 78. Gould E, Woolley CS, McEwen BS. Adrenal steroids regulate postnatal development in the rat dentate gyrus. I. Effects of glucocorticoids on cell death. J Comp Neurol 1991; 313: 479-485.
79. 79. Grosser BI. 11β-Hydroxysteroid metabolism by mouse brain and glioma 261. J Neurochem 1966; 13: 475-478.
80. 80. Grosser BI, Axelrod LR. Conversion of cortisol to cortisol acetate, cortisone acetate and cortisone by the developing primate brain. Steroids 1968; 11: 827-836.
81. 81. Hammami MM, Siiteri PK. Regulation of 11β-hydroxysteroid dehydrogenase activity in human skin fibroblasts: Enzymatic modulation of glucocorticoid action. J Clin Endocrinol Metab 1991; 73: 326-334.
82. 82. Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG, Evans RM. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 1985; 318: 635-641.
83. 83. Holmes MC, French KL, Seckl JR. Modulation of serotonin and corticosteroid receptor gene expression in the rat hippocampus with circadian rhythm and stress. Mol Brain Res 1995; 28: 186-192.
84. 84. Holson RR, Gough B, Sullivan P, Badger T, Sheehan DM. Prenatal dexamethasone or stress but not ACTH or corticosterone alter sexual behavior in male rats. Neurotoxicol Teratol 1995; 17: 393-401.
85. 85. Horner HC, Packan DR, Sapolsky RM. Glucocorticoids inhibit glucose transport in cultured hippocampal neurones and glia. Neuroendocrinology 1990; 52: 57-64.
86. 86. Hubener HJ, Fukushima DK, Gallagher TF. Substrate specificity of enzymes reducing the 11-and 20-keto groups of steroids. J Biol Chem 1956; 220: 499-511.
87. 87. Huff RA, Seidler FJ, Slotkin TA. Glucocorticoids regulate the ontogenic transition of adrenergic receptor subtypes in rat liver. Life Sci 1991; 48: 1059-1065.
88. 88. Hundertmark S, Buhler H, Ragosch V, Dinkelborg L, Arabin B, Weitzel HK. Correlation of surfactant phosphatidylcholine synthesis and 11β-hydroxysteroid dehydrogenase in the fetal lung. Endocrinology 1995; 136: 2573-2578.
89. 89. Issa AM, Rowe W, Gauthier S, Meaney MJ. Hypothalamic-pituitary-adrenal activity in aged, cognitively impaired and cognitively unimpaired rats. J Neurosci 1990; 10: 3247-3254.
90. 90. Jamieson P, Fuchs E, Seckl J. Chronic stress attenuates 11β-hydroxysteroid dehydrogenase activity in the hippocampus and liver of the tree shrew. 10th Int Congress Endocrinol Abstr 1996; P3-S71.
91. 91. Jamieson PM, Chapman KE, Edwards CRW, Seckl JR. 11β-Hydroxysteroid dehydrogenase is an exclusive 11β-reductase in primary cultured rat hepatocytes: Effect of physicochemical and hormonal manipulations. Endocrinology 1995; 136: 4754-4761.
92. 92. Jamieson PM, Chapman KE, Walker BR, Seckl JR. Hepatic 11β-oxidoreductase (11β-HSD-1) enhances glucocorticoid-regulated gene transcription in the rat in vivo by reactivating inert glucocorticoid metabolites. J Endocrinol 1996; 148(Suppl): P44.
93. 93. Janiak P, Brody MJ. Central interactions between aldosterone and vasopressin on cardiovascular system. Am J Physiol 1988; 255: R166-R173.
94. 94. Jellinck PH, Monder C, McEwen BS, Sakai RR. Differential inhibition of 11β-hydroxysteroid dehydrogenase by carbenoxolone in rat brain regions and peripheral tissues. J Steroid Biochem Mol Biol 1993; 46: 209-213.
95. 95. Kageyama Y, Bravo EL. Hypertensive mechanisms associated with centrally administered aldosterone in dogs. Hypertension 1988; 11: 750-753.
96. 96. Koerner DR. Assay and substrate specificity of liver 11β-hydroxysteroid dehydrogenase. Biochim Biophys Acta 1969; 176: 377-382.
97. 97. Kokate TG, Svensson BE, Rogawski MA. Anticonvulsant activity of neurosteroids: Correlation with gamma-aminobutyric acid-evoked chloride current potentiation. J Pharmacol Exp Ther 1994; 270: 1223-1229.
98. 98. König H, Ponta H, Rahmsdorf HJ, Herrlich P. Interference between pathway-specific transcription factors: Glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J 1992; 11: 2241-2246.
99. 99. Krozowski Z, Obeyesekere V, Smith R, Mercer W. Tissue-specific expression of an 11β-hydroxysteroid dehydrogenase with a truncated N-terminal domain. J Biol Chem 1992; 267: 2569-2574.
100. 100. Krozowski ZK, Funder JW. Renal mineralocorticoid receptors and hippocampal corticosterone binding species have identical intrinsic steroid specificity. Proc Nat Acad Sci USA 1983; 80: 6056-6060.
101. 101. Kwak SP, Patel PD, Thompson RC, Akil H, Watson SJ. 5′-Heterogeneity of the mineralocorticoid receptor messenge ribonucleic acid: Differential expression and regulation of splice variants within the rat hippocampus. Endocrinology 1993; 133: 2344-2350.
102. 102. Lakshmi V, Monder C. Evidence for independent 11-oxidase and 11-reductase activities of 11β-hydroxysteroid dehydrogenase: Enzyme latency, phase transition, and lipid requirements. Endocrinology 1985; 116: 552-560.
103. 103. Lakshmi V, Monder C. Purification and characterisation of the corticosteroid 11β-dehydrogenase component of the rat liver 11β-hydroxysteroid dehydrogenase complex. Endocrinology 1988; 123: 2390-2398.
104. 104. Lakshmi V, Sakai RR, McEwen BS, Monder C. Regional distribution of 11β-hydroxysteroid dehydrogenase in rat brain. Endocrinology 1991; 128:1741-1748.
105. 105. Landfield PW. Impaired frequency potentiation as a basis for aging-dependent memory impairment: The role of calcium excess. Neurosci Res Commun 1994; 12(Suppl 1): S19-S22.
106. 106. Landfield PW, Baskin RK, Pitler TA. Brain aging correlates: Retardation by hormonal-pharmacological treatments. Science 1981; 214: 581-584.
107. 107. Landfield PW, Eldridge JC. The glucocorticoid hypothesis of brain aging and neurodegeneration: Recent modifications. Acta Endocrinol 1991; 125: 54-64.
108. 108. Landfield PW, Waymire J, Lynch G. Hippocampal aging and adrenocorticoids: A quantitative correlation. Science 1978; 202: 1098-1102.
109. 109. Langley-Evans SC, Philips G, Benediktsson R, Gardner D, Edwards CRW, Jackson AA, Seckl JR. Maternal dietary protein restriction, placental glucocorticoid metabolism and the programming of hypertension. Placenta 1996; 17:169-172.
110. 110. Langley-Evans SC, Phillips GJ, Jackson AA. In utero exposure to maternal low protein diets induces hypertension in weanling rats independently of maternal blood pressure changes. Clin Nutr 1994; 13: 319-324.
111. 111. Larsen PR, Silva JE, Kaplan MM. Relationships between circulating and intracellular thyroid hormones: Physiological and clinical implications. Endocr Rev 1981; 2: 87-102.
112. 112. Latif S, Conca T, Morris D. The effects of the liquorice derivative, glycyrrhetinic acid on hepatic 3α-and 3β-hydroxysteroid dehydrogenases and 5α-and 5β-reductase pathways of metabolism of aldosterone in male rats. Steroids 1990; 55: 52-58.
113. 113. Lax ER, Ghraf R, Schriefers H. The hormonal regulation of hepatic microsomal 11β-hydroxysteroid dehydrogenase activity in the rat. Acta Endocrinol 1978; 89: 352-357.
114. 114. Lax ER, Ghraf R, Shreifers H, Voigt KH. The involvement of the thyroid and adrenal in the regulation of hepatic and renal steroid metabolism in the rat. Hoppe-Seylers Z Physiol Chem 1979; 360: 137-143.
115. 1 cells model 11β-hydroxysteroid dehydrogenase type 2 regulation of glucocorticoid access to renal mineralocorticoid receptors. Endocrinology 1995; 136: 5561-5569.
116. 116. Levine S. Infantile experience and resistance to physiological stress. Science 1957; 126: 405-406.
117. 117. Levine S. Plasma-free corticosteroid response to electric shock in rats stimulated in infancy. Science 1962; 135: 795-796.
118. 118. Levitt N, Lindsay RS, Holmes MC, Seckl JR. Prenatal dexamethasone programmes attenuated hippocampal glucocorticoid receptor gene expression and elevated basal corticosterone levels in adult life. 77th Am Endocr Soc Abstr 1995; #1-451:225.
119. 119. Lindsay RS, Lindsay RM, Edwards CRW, Seckl JR. Prenatal carbenoxolone, placental 11β-hydroxysteroid dehydrogenase and the programming of blood pressure and insulin resistance. 77th Ann Meet Endocrine Soc 1995; 2-494: 414.
120. 120. Lindsay RS, Lindsay RM, Edwards CRW, Seckl JR. Inhibition of 11β-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring. Hypertension 1996; 27: 1200-1204.
121. 121. Lopez Bernal A, Craft IL. Corticosteroid metabolism in vitro by human placenta, foetal membranes and decidua in early and late gestation. Placenta 1981; 2: 279-285.
122. 122. Lopez-Bernal A, Flint APF, Anderson ABM, Turnbull AC. 11β-hydroxysteroid dehydrogenase activity (E.C.1.1.1.146) in human placenta and decidua. J Steroid Biochem 1980; 13: 1081-1087.
123. 123. Low SC, Assaad SN, Rajan V, Chapman KE, Edwards CRW, Seckl JR. Regulation of 11β-hydroxysteroid dehydrogenase by sex steroids in vivo: Further evidence for the existence of a second dehydrogenase in rat kidney. J Endocrinol 1993; 139: 27-35.
124. 124. Low SC, Chapman KE, Edwards CRW, Seckl JR. Liver-type 11β-hydroxysteroid dehydrogenase cDNA encodes reductase not dehydrogenase activity in intact mammalian COS-7 cells. J Mol Endocrinol 1994; 13: 167-174.
125. 125. Low SC, Chapman KE, Edwards CRW, Wells T, Robinson ICAF, Seckl JR. Female pattern growth hormone secretion mediates the oestrogen-related decrease in hepatic 11β-hydroxysteroid dehydrogenase expression in the rat. J Endocrinol 1994; 143: 541-548.
126. 126. Low SC, Moisan M-P, Edwards CRW, Seckl JR. Glucocorticoids and chronic stress upregulate 11β-hydroxysteroid dehydrogenase activity and gene expression in the hippocampus. J Neuroendocrinol 1994; 6: 285-290.
127. 127. Lupien S, Lecours AR, Lussier I, Schwartz G, Nair NPV, Meaney MJ. Basal cortisol levels and cognitive deficits in human aging. J Neurosci 1994; 14: 2893-2903.
128. 128. Luttge WG, Davda MM, Rupp ME, Kang CG. High affinity binding and regulatory actions of dexamethasone-type I receptor complexes in the mouse brain. Endocrinology 1989; 125: 1194-1203.
129. 129. Luttge WG, Rupp ME, Davda MM. Aldosterone-stimulated down-regulation of both type I and type II adrenocorticosteroid receptors in mouse brain is mediated via type I receptors. Endocrinology 1989; 125: 817-824.
130. 130. Maccari S, Piazza PV, Kabbaj M, Barbazanges A, Simon H, Le Moal M. Adoption reverses the long-term impairment in glucocorticoid feedback induced by prenatal stress. J Neurosci 1995; 15: 110-116.
131. 131. Margarinos AM, Coirini H, De Nicola AF, McEwen BS. Mineralocorticoid regulation of salt intake is preserved in hippocampectomised rats. Neuroendocrinology 1986; 44: 494-497.
132. 132. McCormick CM, Smythe JW, Sharma S, Meaney MJ. Sex-specific effects of prenatal stress on hypothalamic-pituitary-adrenal responses to stress and brain glucocorticoid receptor density in adult rats. Dev Brain Res 1995; 84: 55-61.
133. 133. McEwen BS. Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol Sci 1991; 12: 141-147.
134. 134. McEwen BS. Re-examination of the Glucocorticoid Hypothesis of Stress and Aging. Progress in Brain Research 1992; Amsterdam: Elsevier Science Publishers BV, 1992: 365-383.
135. 135. McEwen BS, de Kloet ER, Rostene W. Adrenal steroid receptors and action in the nervous system. Physiol Rev 1986; 66: 1121-1188.
136. 136. McEwen BS, Lambdin LT, Rainbow TC, De Nicola AF. Aldosterone effects on salt appetite in adrenalectomised rats. Neuroendocrinology 1986; 43: 38-43.
137. 137. McEwen BS, Stephenson B, Krey LC. Radioimmunoassay of brain tissue and cell nuclear corticosterone. J Neurosci Methods 1980; 3: 57-65.
138. 138. McEwen BS, Weiss JM, Schwartz LS. Selective retion of corticosterone by limbic structures in rat brain. Nature 1968; 220: 911-912.
139. 139. Meaney MJ, Aitken DH, Sharma S, Viau V. Basal ACTH, corticosterone and corticosterone-binding globulin levels over the diurnal cycle, and hippocampal corticosteroid receptors in young and aged, handled and non-handled rats. Neuroendocrinology 1992; 55: 204-213.
140. 140. Meaney MJ, Aitken DH, van Berkel C, Bhatnagar S, Sapolsky RM. Effect of neonatal handling on age-related impairments associated with the hippocampus. Science 1988; 239: 766-768.
141. 141. Meaney MJ, Aitken DH, Viau V, Sharma S, Sarrieau A. Neonatal handling alters adrenocortical negative feedback sensitivity and hippocampal type II glucocorticoid receptor binding in the rat. Neuroendocrinology 1989; 50: 597-604.
142. 142. Meaney MJ, Bodnoff SR, O'Donnell D, Sarrieau A, Nair NPV, Diamond DM, Rose GM, Poirier J, Seckl JR. Adrenal glucocorticoids as modulators of hippocampal neuron survival, repair and function in the aged rat. In: Cuello C, Ed. Restorative Neurology. New York: Elsevier, 1993: 267-289.
143. 143. Meaney MJ, O'Donnell D, Viau V, Bhatnagar S, Sarrieau A, Smythe J, Shanks N, Walker C-D. Corticosteroid receptors in the rat brain and pituitary during development and hypothalamic-pituitary-adrenal function. In: Zagon S, McLaughlin PJ, Eds. Growth Factors and Hormones. New York: Chapman & Hall, 1993: 163-201.
144. 144. Mellon SH, Deschepper CF. Neurosteroid biosynthesis: Genes for adrenal steroidogenic enzymes are expressed in the brain. Brain Res 1993; 629: 283-292.
145. 145. Mercer W, Obeyesekere V, Smith R, Krozowski Z. Characterisation of 11β-HSD1B gene expression and enzymatic activity. Mol Cell Endocrinol 1993; 92: 247-251.
146. 146. Meyer JS. Biochemical effects of corticosteroids on neural tissues. Physiol Rev 1985; 65: 946-1020.
147. 147. Miyabo S, Kishida S, Hisada T. Metabolism and conjugation of cortisol by various dog tissues in vitro. J Steroid Biochem 1973; 4: 567-576.
148. 148. Moisan M-P, Edwards CRW, Seckl JR. Differential promoter usage by the rat 11β-hydroxysteroid dehydrogenase gene. Mol Endocrinol 1992; 6: 1082-1087.
149. 149. Moisan M-P, Edwards CRW, Seckl JR. Ontogeny of 11β-hydroxysteroid dehydrogenase in rat brain and kidney. Endocrinology 1992; 130: 400-404.
150. 150. Moisan M-P, Seckl JR, Brett LP, Monder C, Agarwal AK, White PC, Edwards CRW. 11β-Hydroxysteroid dehydrogenase messenger ribonuceic acid expression, bioactivity and immunoreactivity in rat cerebellum. J Neuroendocrinol 1990; 2: 853-858.
151. 151. Moisan M-P, Seckl JR, Edwards CRW. 11β-Hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain: Localization in hypothalamus, hippocampus and cortex. Endocrinology 1990; 127: 1450-1455.
152. 152. Moisan M-P, Seckl JR, Edwards CRW Effect of adrenalectomy and dexamethasone administration on 11β-hydroxysteroid dehydrogenase in vitro activity in rat brain and kidney. J Physiol 1991; 434: 87P.
153. 153. Monder C. Corticosteroids, kidneys, sweet roots and dirty drugs. Mol Cell Endocrinol 1991; 78: C95-C98.
154. 154. Monder C. Corticosteroids, receptors, and organ-specific functions of 11β-hydroxysteroid dehydrogenase. FASEB J 1991; 5: 3047-3054.
155. 155. Monder C, Lakshmi V. Corticosteroid 11β-dehydrogenase of rat tissues: immunological studies. Endocrinology 1990; 126: 2435-2443.
156. 156. Monder C, Miroff Y, Marandici A, Hardy MP. 11β-Hydroxysteroid dehydrogenase alleviates glucocorticoid-mediated inhibition of steroidogenesis in rat Leydig cells. Endocrinology 1994; 134: 1199-1204.
157. 157. Monder C, Sakai RR, Miroff Y, Blanchard DC, Blanchard RJ. Reciprocal changes in plasma corticosterone and testosterone in stressed male rats maintained in a visible burrow system: Evidence for a mediating role of testicular 11β-hydroxysteroid dehydrogenase. Endocrinology 1994; 134: 1193-1198.
158. 158. Monder C, Shackleton CHL. 11β-Hydroxysteroid dehydrogenase: Fact or fancy? Steroids 1984; 44: 383-415.
159. 159. Monder C, Stewart PM, Lakshmi V, Valentino R, Burt D, Edwards CRW. Licorice inhibits corticosteroid 11β-dehydrogenase of rat kidney and liver: In vivo and in vitro studies. Endocrinology 1989; 125: 1046-1053.
160. 160. Monder C, White PC. 11β-Hydroxysteroid dehydrogenase. Vitamins Horm 1993; 47: 187-271.
161. 161. Moore CCD, Mellon SH, Murai J, Siiteri PK, Miller WL. Structure and function of the hepatic form of 11β-hydroxysteroid dehydrogenase in the squirrel monkey, an animal model of glucocorticoid resistance. Endocrinology 1993; 133: 368-375.
162. 162. Mune T, Rogerson FM, Nikkilä H, Agarwal AK, White PC. Human hypertension caused by mutations in the kidney isozyme of 11ββ-hydroxysteroid dehydrogenase. Nature Genet 1995; 10: 394-399.
163. 163. Murphy BEP. Demonstration of novel compounds in human fetal tissues and a consideration of their possible role in parturition. Am J Obstet Gynecol 1981; 139: 353-358.
164. 164. Murphy BEP. Ontogeny of cortisol cortisone interconversion in human tissues: A role of cortisone during development. J Steroid Biochem 1981; 14: 811-817.
165. 165. Murphy BEP, Clark SJ, Donald IR, Pinsky M, Vedady DL. Conversion of maternal cortisol to cortisone during placental transfer to the human fetus. Am J Obstet Gynecol 1974; 118: 538-541.
166. 166. Nagomi H, Tachibana T. Dexamethasone induces advanced growth hormone expression in the fetal rat pituitary. Endocrinology 1993; 132: 517-523.
167. 167. Náray-Fejes-Tóth A, Fejes-Tóth G. Expression cloning of the aldosterone target cell-specific 11β-hydroxysteroid dehydrogenase from rabbit collecting duct cells. Endocrinology 1995; 136: 2579-2586.
168. 168. Navarro HA, Kudlacz EM, Eylers JP, Slotkin TA. Prenatal dexamethasone administration disrupts the pattern of cellular development in rat lung. Teratology 1989; 40: 433-438.
169. 169. Nightingale S, Smith PE, Turnbull DM. Anorexia nervosa, liquorice and hypokalaemic myopathy. Postgraduate Medical Journal 1981; 57: 577-579.
170. 170. Nikkilä H, Tannin GM, Taylor NF, Kalaitzoglou G, Monder C, White PC. Defects in the HSD11 gene encoding 11β-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency. Endoc Soc Abstr 1993; 75: #410, p 153.
171. 171. Nitabach MN, Schulkin J, Epstein A. The medial amygdala is part of a mineralocorticoid-sensitive circuit controlling NaCl ingestion in the rat. Behav Brain Res 1989; 35: 159-161.
172. 172. O'Donnell D, La Roque S, Seckl JR, Meaney M. Postnatal handling alters glucocorticoid but not mineralocorticoid receptor mRNA expression in the hippocampus of adult rats. Mol Brain Res 1994; 26: 242-248.
173. 173. Obeid J, Curnow KM, Aisenberg J, White PC. Transcripts originating in intron 1 of the HSD11 (11β-hydroxysteroid dehydrogenase) gene encode a truncated polypeptide that is enzymatically inactive. Mol Endocrinol 1993; 7: 154-160.
174. A antagonist in the guinea pig isolated ileum. J Pharm Pharmacol 1990; 42: 662-664.
175. 175. Orchinik M, Murray TF, Moore FL. A corticosteroid receptor in neuronal membranes. Science 1991; 252: 1848-1851.
176. 176. Ozols J. Lumenal orientation and post-translational modification of the liver microsomal 11β-hydroxysteroid dehydrogenase. J Biol Chem 1995; 270: 2305-2312.
177. 177. Packan DR, Sapolsky RM. Glucocorticoid endangerment of the hippocampus: Tissue, steroid and receptor specificity. Neuroendocrinology 1990; 51: 613-618.
178. 178. Palkovits M, Monos E, Facher J. The effect of subcommissural organ lesions on aldosterone production in the rat. Acta Endocrinol 1965; 48: 169-176.
179. 179. Patel PD, Sherman TG, Goldman DJ, Watson SJ. Molecular cloning of a mineralocorticoid (type I) receptor complimentary DNA from rat hippocampus. Mol Endocrinol 1990; 3: 1877-1885.
180. 180. Pearce D, Yamamoto KR. Mineralocorticoid and glucocorticoid receptor activities distinguished by non-receptor factors at a composite response element. Science 1993; 259: 1161-1165.
181. 181. Peterson NA, Chaikoff IL, Jones C. The in vitro conversion of cortisol to cortisone by subcellular brain fractions of young and adult rats. J Neurochem 1965; 12: 273-278.
182. 182. Pfahl M. Nuclear receptor/AP-1 interactions. Endocr Rev 1993; 14: 651-658.
183. 183. Phillipou G, Higgins BA. A defect in the peripheral conversion of cortisone to cortisol. J Steroid Biochem 1985; 22: 435-436.
184. 184. Phillips MD, Lakshmi V, Monder C. Corticosteroid 11β-dehydrogenase in rat testis. Endocrinology 1989; 125: 209-216.
185. 185. Rajan V, Chapman KE, Lyons V, Jamieson P, Mullins JJ, Edwards CRW, Seckl JR. Cloning sequencing and tissue-distribution of mouse 11β-hydroxysteroid dehydrogenase-1 cDNA. J Steroid Biochem Mol Biol 1995; 52: 141-147.
186. 186. Rajan V, Edwards CRW, Seckl JR. 11β-Hydroxysteroid dehydrogenase in cultured hippocampal cells reactivates inert 11-dehydrocorticosterone, potentiating neurotoxicity. J Neurosci 1996; 16: 65-70.
187. 187. Reul JMHM, de Kloet ER. Two receptor systems for corticosterone in rat brain: microdissection and differential occupation. Endocrinology 1985; 117: 2505-2511.
188. 188. Reul JMHM, de Kloet ER. Anatomical resolution of two types of corticosterone receptor sites in rat brain with in vivo autoradiography and computerised image analysis. J Steroid Biochem 1986; 24: 269-272.
189. 189. Reul JMHM, Stec I, Wiegers GJ, Labeur MS, Linthorst ACE, Artz E, Holsboer F. Prenatal immune challenge alters the hypothalamic-pituitary-adrenocortical axis in adult rats. J Clin Invest 1994; 93: 2600-2607.
190. 190. Reul JMHM, van den Bosch FR, de Kloet ER. Relative occupation of type-I and type-II corticosteroid receptors in rat brain following stress and dexamethasone treatment: Functional implications. J Endocrinol 1987; 115: 459-467.
191. 191. Robel P, Baulieu EE. Neurosteroids: Biosynthesis and function. Trends Endocrinol Metab 1994; 5: 1-8.
192. 192. Roland BL, Krozowski ZS, Funder JW Glucocorticoid receptor, mineralocorticoid receptors and 11β-hydroxysteroid dehydrogenase-1 and -2 expression in rat brain and kidney: In situ studies. Mol Cell Endocrinol 1995; 111: R1-R7.
193. 193. Roland BL, Li KXZ, Funder JW Hybridization histochemical localization of 11β-hydroxysteroid dehydrogenase type 2 in rat brain. Endocrinology 1995; 136: 4697-4700.
194. 194. Rundle C, Funder J, Lakshmi V, Monder C. The intrarenal localization of mineralocorticoid receptors and 11β-dehydrogenase: Immunocytochemical studies. Endocrinology 1989; 125: 1700-1704.
195. 195. Rupprecht R, Arriza JL, Sprengler D, Reul JMHM, Evans RM, Hosboer F, Damm K. Transactivation and synergistic properties of the mineralocorticoid receptor: relationship to the glucocorticoid receptor. Mol Endocrinol 1993; 7: 597-603.
196. 196. Rusvai E, Náray-Fejes-Tóth A. A new isoform of 11β-hydroxysteroid dehydrogenase in aldosterone target cells. J Biol Chem 1993; 268: 10717-10720.
197. 197. Sakai R, Lakshmi V, Monder C, McEwen B. Presence of 11β-hydroxysteroid dehydrogenase in the hippocampus of the rat. Soc Neurosci Abstr 1989; 15: 717.
198. 198. Sakai RR, Lakshmi V, Monder C, Funder JW, Krozowski Z, McEwen BS. Colocalization of 11β-hydroxysteroid dehydrogenase and mineralocorticoid receptor in rat brain. Soc Neurosci Abstr 1990; #7773.
199. 199. Sakai RR, Lakshmi V, Monder C, McEwen BS. Immunocytochemical localisation of 11beta-hydroxysteroid dehydrogenase in hippocampus and other brain regions of the rat. J Neuroendocrinol 1992; 4: 101-106.
200. 200. Sakai RR, Nicolaidis S, Epstein AN. Salt appetite is suppressed by interference with angiotensin II and aldosterone. Am J Physiol 1986; 251: R762-R768.
201. 201. Sanders BJ, Knardahl S, Johnson AK. Lesions of the anteroventral third ventricle and development of stress-induced hypertension in the borderline hypertensive rat. Hypertension 1989; 13: 817-821.
202. 202. Sapolsky RM. A mechanism for glucocorticoid toxicity in the hippocampus: Increased neuronal vulnerability to metabolic insults. J Neurosci 1985; 5:1228-1232.
203. 203. Sapolsky RM. Glucocorticoid neurotoxicity in the hippocampus: synergy with kainic acid. Neuroendocrinology 1986; 43: 386-391.
204. 204. Sapolsky RM. Glucocorticoid toxicity in the hippocampus: Reversal by supplementation with brain fuels. J Neurosci 1986; 2: 2240-2247.
205. 205. Sapolsky RM. Stress, the Aging Brain and the Mechanisms of Neuron Death. Cambridge, MA: MIT, 1992: 429.
206. 206. Sapolsky RM, Krey LC, McEwen BS. Prolonged glucocorticoid exposure reduces hippocampal neuron number: Implications for aging. J Neurosci 1985; 5: 1221-1226.
207. 207. Sapolsky RM, Krey LC, McEwen BS. The neuroendocrinology of stress and ageing. The glucocorticoid cascade hypothesis. Endocr Rev 1986; 7: 284-301.
208. 208. Sapolsky RM, Krey LC, McEwen BS, Rainbow TC. Do vasopressin-related peptides induce hippocampal corticosteroid receptors? Implications for aging. J Neurosci 1984; 4: 1479-1485.
209. 209. Schulkin J, Angulo J, Sakai RR, McEwen BS. Expression of salt hunger in hypophysectomized rats. Neuroendocrinology 1989; 50: 447-454.
210. 210. Seckl JR. 11β-Hydroxysteroid dehydrogenase isoforms and their implications for blood pressure regulation. Eur J Clin Invest 1993; 23: 589-601.
211. 211. Seckl JR. Glucocorticoids and small babies. Quart J Med 1994; 87: 259-262.
212. 212. Seckl JR. Expression and properties of adrenal steroid receptors in the CNS. In: Stone T, Ed. CNS Neurotransmitters and Neuromodulators: Neuroactive Steroids. Boca Ranton: CRC Press, 1996: 1-22.
213. 213. Seckl JR, Brown RW. 11β-Hydroxysteroid dehydrogenase: On several roads to hypertension. J Hyperten 1994; 12: 105-112.
214. 214. Seckl JR, Dow RC, Low SC, Edwards CRW, Fink G. The 11β-hydroxysteroid dehydrogenase inhibitor glycyrrhetinic acid affects corticosteroid feedback regulation of hypothalamic corticotrophin-releasing peptides. J Endocrinol 1993; 136: 471-477.
215. 215. Seckl JR, Kelly PAT, Sharkey J. Glycyrrhetinic acid, an inhibitor of 11β-hydroxysteroid dehydrogenase, alters local cerebral glucose utilization in vivo. J Steroid Biochem Mol Biol 1991; 39: 777-779.
216. 216. Seckl JR, Olsson T. Glucocorticoids and the age-impaired hippocampus: Cause or effect? J Endocrinol 1995; 145: 201-211.
217. 217. Sheppard K, Funder JW. Mineralocorticoid specificity of renal type 1 receptors: In vivo binding studies. Am J Physiol 1987; 252: E224-E229.
218. 218. Sheward WJ, Fink G. Effects of corticosterone on the secretion of corticotrophin-releasing factor, arginine vasopressin and oxytocin into hypophysial portal blood in long-term hypophysectomised rats. J Endocrinol 1991; 129.
219. 14C by rat brain homogenates. Metab Clin Exp 1965; 14: 1122-1127.
220. 220. Silva CM, Powell-Oliver FE, Jewell CM, Sar M, Allgood VE, Cidlowski JA. Regulation of the human glucocorticoid receptor by long-term and chronic treatment with glucocorticoid. Steroids 1994; 59: 436-442.
221. 221. Slotkin TA, Lau C, McCook EC, Lappi SE, Seidler FJ. Glucocorticoids enhance intracellular signaling via adenylate cyclase at three distinct loci in the fetus: A mechanism for heterologous teratogenic sensitization? Toxicol Applied Pharmacol 1994; 127: 64-75.
222. 222. Sloviter RS, Valiquette G, Abrams GM, Ronk EC, Sollas AL, Paul LA, Neubort S. Selective loss of hippocampal granule cells in the mature rat brain after adrenalectomy. Science 1989; 243: 535-538.
223. 223. Smith RE, Mercer WR, Provencher PH, Obeyesekere V, Krozowski ZS. The heterogeneity of 11β-hydroxysteroid dehydrogenase activities in the rat hippocampus implies a complex regulation of steroid hormone action. Clin Exp Pharmacol Physiol 1992; 19: 365-368.
224. 224. Sobotka TJ, Spaid SL, Brodie RE, Reed GF. Neurobehavioral toxicity of ammoniated glycyrrhizin, a licorice component, in rats. Neurobehav Toxicol Teratol 1981; 3: 37-44.
225. 225. Sousa RJ, Tannery NH, Lafer EM. In situ hybridization mapping of glucocorticoid receptor messenger ribonucleic acid in rat brain. Mol Endocrinol 1989; 3: 481-494.
226. 226. Starkman MN, Gebarski SS, Berent S, Schteingart DE. Hippocampal formation volume, memory dysfunction and cortisol levels in patients with Cushing's syndrome. Biol Psychiatry 1992; 32: 756-765.
227. 227. Stewart PM, Corrie JET, Shackleton CHL, Edwards CW Syndrome of apparent mineralocorticoid excess: A defect in the cortisol-cortisone shuttle. J Clin Invest 1988; 82: 340-349.
228. 228. Stewart PM, Murry BA, Mason JI. Type 2 11β-hydroxysteroid dehydrogenase in human fetal tissues. J Clin Endocrinol Metab 1994; 78: 1529-1532.
229. 229. Stewart PM, Rogerson FM, Mason JI. Type 2 11β-hydroxysteroid dehydrogenase messenger RNA and activity in human placenta and fetal membranes: Its relationship to birth weight and putative role in fetal steroidogenesis. J Clin Endocrinol Metab 1995; 80: 885-890.
230. 230. Stewart PM, Valentino R, Wallace AM, Burt D, Shackleton CHL, Edwards CRW. Mineralocorticoid activity of liquorice: 11β-hydroxysteroid dehydrogenase deficiency comes of age. Lancet 1987; ii: 821-824.
231. 231. Stewart PM, Wallace AM, Atherden SM, Shearing CH, Edwards CRW. Mineralocorticoid activity of carbenoxolone: Contrasting effects of carbenoxolone and liquorice on 11β-hydroxysteroid dehydrogenase activity in man. Clin Sci 1990; 78: 49-54.
232. 232. Stormer FC, Reistad R, Alexander J. Glycyrrhizic acid in liquorice - Evaluation of health hazard. Food Chem Toxicol 1993; 31: 303-312.
233. 233. Swanson LW, Simmons DM. Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: A hybridization histochemical study in the rat. J Comp Neurobiol 1989; 285: 413-435.
234. 234. Takahashi LK, Turner JG, Kalin NM. Prenatal stress alters brain catecholaminergic activity and potentiates stress-induced behavior in adult rats. Brain Res 1992; 574: 131-137.
235. 235. Tannin GM, Agarwal AK, Monder C, New MI, White PC. The human gene for 11β-hydroxysteroid dehydrogenase. J Biol Chem 1991; 266: 16653-16658.
236. 236. Teelucksingh S, Benediktsson R, Lindsay RS, Burt D, Seckl JR, Edwards CRW, Li Nan C, Kelly R. Liquorice. Lancet 1991; 337: 1549.
237. 237. Teelucksingh S, Mackie A, Burt D, McIntyre M, Brett L, Edwards C. Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid. Lancet 1990; 335: 1060-1063.
238. 238. Temple DL, Leibowitz SF. PVN steroid implants: Effect on feeding patterns and micronutrient selection. Brain Res Bull 1989; 23: 553-560.
239. 239. Temple DL, Leibowitz SF. Adrenal steroid receptors: Interactions with brain neuropeptide systems in relation to nutrient intake and metabolism. J Neuroendocrinol 1994; 6: 479-501.
240. 240. Trapp T, Rupprecht R, Castren M, Reul JMHM, Holsboer F. Heterodimerization between mineralocorticoid and glucocorticoid receptor: A new principle of glucocorticoid action in the CNS. Neuron 1994; 13: 1457-1462.
241. 241. Tye LM, Burton AF. Variation in the pattern of metabolism of corticosteroids in fetal mouse tissues. Life Sci 1980; 26: 35-39.
242. 242. Uno H, Eisele S, Sakai A, Shelton S, Baker E, DeJesus O, Holden J. Neurotoxicity of glucocorticoids in the primate brain. Harm Behav 1994; 28: 336-348.
243. 243. Van den Berg DTWM, De Jong W, De Kloet ER. Mineralocorticoid antagonist inhibits stress-induced blood pressure response after repeated daily warming. Am J Physiol Endocrinol Metab 1994; 267: E921-E926.
244. 244. Van den Berg DTWM, De Kloet ER, De Jong W Central effects of mineralocorticoid antagonist RU-28318 on blood pressure of DOCA-salt hypertensive rats. Am J Physiol 1994; 267: E927-E933.
245. 245. van den Berg DTWM, de Kloet ER, van Dijken HH, de Jong W. Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure. Endocrinology 1990; 126: 118-124.
246. 246. van der Zwan A. Hypertension encephalopathy after liquorice ingestion. Clin Neural Neurosurg 1993; 95: 35-38.
247. 247. Van Eekelen JAM, Jiang W, de Kloet ER, Bohn MC. Distribution of the mineralocorticoid and the glucocorticoid receptor mRNAs in the rat hippocampus. J Neurosci Res 1988; 21: 88-94.
248. 248. Van Giersbergen P, Palkovits M, De Jong W. Involvement of neurotransmitters in the nucleus tractus solitarii in cardiovascular regulation. Physiol Rev 1992; 72: 789-824.
249. 249. Velasquez PN, Romano MC. Corticosterone therapy during gestation: effects on the development of rat cerebellum. Int J Dev Neurosci 1990; 5: 189-194.
250. 250. Voice MW, Seckl JR, Edwards CRW, Chapman KE. 2S-FAZA cells express type l 11β-hydroxysteroid dehydrogenase in a hormonally regulated manner. J Endocrinol 1995; 147(Suppl): O22.
251. 251. Walker BR, Campbell JC, Fraser R, Stewart PM, Edwards CRW Mineralocorticoid excess and inhibition of 11β-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome. Clin Endocrinol 1992; 37: 483-492.
252. 252. Walker BR, Connacher AA, Lindsay RM, Webb DJ, Edwards CRW Carbenoxolone increases hepatic insulin sensitivity in man: A novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. J Clin Endocrinol Metab 1995; 80: 3155-3159.
253. 253. Walker BR, Edwards CRW. 11β-Hydroxysteroid dehydrogenase and enzyme-mediated receptor protection: Life after liquorice. Clin Endocrinol 1991; 35: 281-289.
254. 254. Walker BR, Williams BC, Edwards CRW. Regulation of 11β-hydroxysteroid dehydrogenase activity by the hypothalamic-pituitary-adrenal axis in the rat. J Endocrinol 1994; 141: 467-472.
255. 255. Wehling M. Novel aldosterone receptors: Specificity-conferring mechanism at the level of the cell membrane. Steroids 1994; 59: 160-163.
256. 256. Weiland NG, Orchinik M, McEwen BS. Corticosterone regulates mRNA levels of specific subunits of the NMDA receptor in the hippocampus but not the cortex of rats. Soc Neurosci Abstr 1995; 21: 502(207.12).
257. 257. Weindl A. Neuroendocrine Aspects of Circumventricular Organs. Frontiers in Neuroendocrinology 1973; New York: Oxford Univ. Press, 1973: 3-32.
258. 258. Weinstock M, Matlina E, Maor GI, Rosen H, McEwen BS. Prenatal stress selectively alters the reactivity of the hypothalamic-pituitary adrenal system in the female rat. Brain Res 1992; 595: 195-200.
259. 259. Wilson RC, Krozowski ZS, Li K, Obeyesekere VR, Razzaghy-Azar M, Harbison MD, Wei JQ, Shackleton CHL, Funder JW, New MI. A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab 1995; 80: 2263-2266.
260. 260. Woolley C, Gould E, McEwen BS. Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurones. Brain Res 1990; 531: 225-231.
261. 261. Wrange O, Yu Z-Y Mineralocorticoid receptor in rat kidney and hippocampus: characterisation and quantitation by isoelectric focusing. Endocrinology 1983; 113:243-250.
262. 262. Yang K, Matthews SG, Challis JRG. Developmental and glucocorticoid regulation of pituitary 11beta-hydroxysteroid dehydrogenase 1 gene expression in the ovine fetus and lamb. J Mol Endocrinol 1995; 14: 109-116.
263. 263. Yang K, Smith CL, Dales D, Hammond GL, Challis JR. Cloning of an ovine 11 beta-hydroxysteroid dehydrogenase complementary deoxyribonucleic acid: tissue and temporal distribution of its messenger ribonucleic acid during fetal and neonatal development. Endocrinology 1992; 131: 2120-2126.
264. 264. Yongue BG, Roy EJ. Endogenous aldosterone and corticosterone in brain cell nuclei of adrenal-intact rats: Regional distribution and effects of physiological variations in serum steroids. Brain Res 1987; 436: 49-61.
265. 265. Zhou M-Y, Gomez-Sanchez EP, Cosby D, Gomez-Sanchez CE. Cloning of a NAD+-dependent 11β-hydroxysteroid dehydrogenase from rat kidney. Endocrine Soc Abstr 1995; 77: 413.